FIELD: medicine.
SUBSTANCE: what is presented is a therapeutic agent possessing neuroprotective action in ischemic cerebral injury and hypoxia, representing magnesium 2-aminoethanesulfonate (magnesium taurinate). It has been shown that magnesium taurinate possesses high neuroprotective action; therapeutic application of magnesium 2-aminoethanesulfonate 50 mg/kg in cerebral ischemia caused by one-side occlusion of a left carotid, and prevents the developing ischemic cerebral injuries more effectively than if applying Picamilonum. There are also presented: solid dosage pharmaceutical composition on the basis of this compound in the form of tablets, capsules, powders, and a pharmaceutical composition for injections.
EFFECT: neuroprotective properties enable the presented pharmaceutical compositions of magnesium taurinate suggested to be used for preventing and treating ischemic cerebral injures.
6 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
MAGNESIUM BIS (2-AMINOETHANESULFONIC ACID)-BUTANEDIOATE, WHICH HAS ANTIHYPOXIC, NEUROPROTECTIVE AND HYPOCOAGULANT ACTIVITY | 2017 |
|
RU2671982C1 |
INJECTION DRUG FORMULATION WITH NEUROPROTECTIVE PROPERTIES | 2006 |
|
RU2331414C1 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTIINFLAMMATORY, BRONCHOLYTIC, ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2448961C1 |
2-(DIETHYLAMINO)-N-(2,6-DIMETHYLPHENYL)ACETAMIDE L-GLUTAMATE, HAVING PROLONGED ANTIARRHYTHMIC ACTIVITY, PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2697717C1 |
2-ETHYL-6-METHYL-3-HYDROXYLIRIDINIUMHYDROXYBUTANEDIOAT EXPRESSING ANTI-ISHEMIC, CEREBROPROTECTIVE, NEUROTROPIC AND LIPID-REGULATING ACTIVITY, PHARMACEUTICAL COMPOSITIONS AND MEDICAL PRODUCT | 2008 |
|
RU2377237C1 |
DIETARY FOOD SUPPLEMENT (DFS) FOR BRAIN PROTECTION | 2020 |
|
RU2790587C2 |
PHARMACEUTICAL COMPOSITION POSSESSING PROLONGED ANTIARRHYTHMIC ACTIVITY | 2012 |
|
RU2538674C2 |
SOLID DOSAGE DRUG FORMULATION, INCREASING PHYSICAL AND MENTAL PERFORMANCE | 2006 |
|
RU2331413C1 |
AGENT POSSESSING ANTIOXIDANT AND NEUROPROTECTIVE PROPERTIES | 2018 |
|
RU2686098C1 |
PHARMACEUTICAL COMPOSITIONS CONTAINING S-AMLODIPINE NICOTINATE AND USING THEM IN TREATING CEREBROVASCULAR DISORDERS | 2012 |
|
RU2516922C2 |
Authors
Dates
2012-06-20—Published
2010-12-09—Filed